Compare Blackstone Inc (BX) vs Ginkgo Bioworks Holdings Inc (DNA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Blackstone Inc vs Ginkgo Bioworks Holdings Inc — how do they compare? Blackstone Inc trades at $147.84 (market cap $117.44B), while Ginkgo Bioworks Holdings Inc trades at $7.51 (market cap $505.73M). The key difference: Blackstone Inc is far larger — about 232.2× Ginkgo Bioworks Holdings Inc's market cap, and Blackstone Inc pays a 3.55% dividend while Ginkgo Bioworks Holdings Inc pays none. Which is the better fit depends on your goals.
| BX | DNA | |
|---|---|---|
Market Cap | $117.44B | $505.73M |
Sector | Financials | Health |
52-Week High | $188.68 | $16.14 |
52-Week Low | $102.12 | $5.48 |
Dividend Yield | 3.55% | — |
Enterprise Value | — | $607.68M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Blackstone Inc
Blackstone is one of the world's largest alternative asset managers with $940.8 billion in total asset under management, including $683.8 billion in fee-earning asset under management, at the end of June 2022.
Read more on BX →About Ginkgo Bioworks Holdings Inc
Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.
Read more on DNA →
